- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03638674
Evaluation of Agreement Between CT Scan and 3D-DXA Measurements on the Lombar Spine (3D DXA SPINE)
September 27, 2022 updated by: Centre Hospitalier Universitaire de Nīmes
Dual-energy X-ray Absorptiometry is frequently used to measure bone mineral density.
A new medical device, Box 3D DXA, creates a 3D image using a statistics reconstruction model developed on the femur.
This new imaging technique does not require additional irradiation and ought to improve bone measures as well as incorporating densitometric parameters into the diagnosis.
This study will test the reconstruction of the 3D image from lombar spine measurements and compare accuracy against measurements made using CT scan.
Study Overview
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nîmes, France, 30029
- CHU Nîmes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The patient must have given their free and informed consent and signed the consent form
- The patient must be a member or beneficiary of a health insurance plan
- The patient is at least 18 years old
- The patient has been referred by a doctor for a PET/CT (Positron Emission Tomography-Computed Tomography) scan or a SPECT (Single Photon Emission Computed Tomography) scan in the Nuclear Medicine and Medical Biophysics Department of Nimes hospital or a bone scan including a SPECT/CT (single photon emission computed tomography coupled with a CT scan)
Exclusion Criteria:
- The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
- The subject refuses to sign the consent
- It is impossible to give the subject informed information
- The patients is under judicial protection or state guardianship
- The patient is pregnant or breast feeding
- The subject has a observably serious scoliosis
- Subject has previously had spinal or hip surgery
- Subject weighs more than 200kg and/or is more than 2 meters tall by 5+65cm wide and 70cm diameter
- Patient uses an insulin pump or wears an insulin or morphine tubing or any attenuating equipment affecting the hips or lumbar spine
- Subject has already had an X-ray exam using a contrast product such as barium in the 7 days preceding the visit
- Subject having undergone γ radiation exam in the 15 days preceding the visit
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 2nd lumbar spine acquisition in same position
spine and hip STRATOS DR + 2nd lumbar spine acquisition in same position (with template)
|
Two dual-energy X-ray scans + CT scan
|
Active Comparator: 2nd lumbar spine acquisition
spine and hip STRATOS DR + 2nd lumbar spine acquisition (no template)
|
Two dual-energy X-ray scans + CT scan
|
Active Comparator: 2nd hip acquisition in same position
spine and hip STRATOS DR + 2nd hip acquisition in same position (with template)
|
Two dual-energy X-ray scans + CT scan
|
Active Comparator: 2nd hip acquisition
spine and hip STRATOS DR + 2nd hip acquisition (without template)
|
Two dual-energy X-ray scans + CT scan
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Concordance in lombar spine measurements between box 3D-DXA (index test) and CT scan (reference test)
Time Frame: Day 0
|
Lin's concordance coefficient
|
Day 0
|
Concordance in lombar spine measurements between box 3D-DXA (index test) and CT scan (reference test)
Time Frame: Day 0
|
Bland Altman plot
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reproducibility of the 3D-DXA Spine algorithm for lombar spine measurements
Time Frame: Day 0
|
2 acquisitions under the same conditions.
Using root-mean-square coefficient of variation to calculate the Least Significant Change
|
Day 0
|
Robustness of 3D-DXA Spine measurement for lombar spine measurements
Time Frame: Day 0
|
2 acquisitions under the same conditions.
Using interquartile range as a measure of dispersion of the variable
|
Day 0
|
Concordance in femur measurements between box 3D-DXA (index test) and CT scan (reference test)
Time Frame: Day 0
|
Lin's concordance coefficient
|
Day 0
|
Concordance in femur measurements between box 3D-DXA (index test) and CT scan (reference test)
Time Frame: Day 0
|
Bland Altman plot
|
Day 0
|
Reproducibility of the 3D-DXA Femur algorithm for femur measurements
Time Frame: Day 0
|
2 acquisitions under the same conditions.
Using root-mean-square coefficient of variation to calculate the Least Significant Change
|
Day 0
|
Robustness of 3D-DXA Femur measurement for femur measurements
Time Frame: Day 0
|
2 acquisitions under the same conditions.
Using interquartile range as a measure of dispersion of the variable
|
Day 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 26, 2019
Primary Completion (Actual)
August 20, 2021
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
August 2, 2018
First Submitted That Met QC Criteria
August 16, 2018
First Posted (Actual)
August 20, 2018
Study Record Updates
Last Update Posted (Actual)
September 28, 2022
Last Update Submitted That Met QC Criteria
September 27, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LOCAL/2016/VB-01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Fracture
-
Cairo UniversityCompletedClavicle Fracture | Bone Fracture | Bone LesionEgypt
-
Corporacion Parc TauliUnknownScaphoid Bone FractureSpain
-
VieCuri Medical CentreCompletedBone FractureNetherlands
-
Sheffield Children's NHS Foundation TrustUnknown
-
IWK Health CentreCompletedSplints | Metacarpal Fracture | Bone Fractures | Boxer's FractureCanada
-
Instituto Venezolano de Investigaciones CientificasHospital Central Dr. Plácido D. Rodriguez Rivero; Instituto Autónomo Hospital...Enrolling by invitationPseudarthrosis | Non Union Fracture | Pseudoarthrosis of Bone | Nonunion Bone FractureVenezuela
-
Damanhour UniversityCompleted
-
Barts & The London NHS TrustLondon DeaneryCompletedLong Bone Fracture | Vitamin DUnited Kingdom
-
IlluminOss Medical, Inc.CompletedHumerus Pathological FractureAustria, Germany, Netherlands
-
Bone Therapeutics S.ACompletedBone Fracture | Validation Studies | Fracture Healing | X-Ray | Delayed Union Fracture | CT-scanGermany
Clinical Trials on DXA + CT
-
Central Hospital, Nancy, FranceUnknown
-
Sheffield Teaching Hospitals NHS Foundation TrustMedical Research Council; Hologic, Inc.Completed
-
Washington D.C. Veterans Affairs Medical CenterUnknown
-
University of IowaRecruitingAsthma | Bone Density, Low | Oral Steroid-Dependent Asthma (Disorder)United States
-
Tongji HospitalUnknownChronic Kidney Disease-Mineral and Bone DisorderChina
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioRecruitingBone Resorption | Arthroplasty ComplicationsItaly
-
Sheffield Children's NHS Foundation TrustUniversity of SheffieldCompleted
-
Swiss Paraplegic Research, NottwilCompleted
-
State University of New York - Upstate Medical...CompletedRegional Osteoporosis as a Result of ChemotherapyUnited States
-
Assiut UniversityNot yet recruiting